Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation

Int J Hematol. 2021 Dec;114(6):701-708. doi: 10.1007/s12185-021-03214-7. Epub 2021 Sep 7.

Abstract

Background: Bronchiolitis obliterans syndrome (BOS) remains one of the most devastating manifestations of chronic graft-versus-host disease in hematopoietic cell transplantation (HCT). Recent findings of BOS after lung transplantation indicate that donor (lung)-derived lung-resident macrophages contribute to BOS, suggesting that differences in the origin of immune cells and localized antigen-presenting cells cause the onset of BOS.

Methods: We identified the phenotype and origin of infiltrating macrophages using immunohistochemistry and fluorescence in situ hybridization in eight sex-mismatched HCT recipients who underwent lung transplantation for BOS after HCT.

Results: Most of the infiltrating macrophages appeared to be derived from donor (hematopoietic) cells in patients who developed BOS following HCT. Macrophages observed in the early-stage region of BOS were positive for cluster of differentiation (CD)68 and inducible nitric oxide synthase (iNOS) and negative for CD163 and CD206, suggesting an M1 phenotype. In the late-stage region, macrophages were negative for CD68 and iNOS in all patients, but also positive for CD163 and CD206 in some patients.

Conclusions: Donor-derived M1-macrophages may be involved in the pathogenesis of the early-stage region of BOS. In addition, some macrophages in the late-stage region showed M2 polarization that might be involved in fibrosis.

Keywords: Allogeneic hematopoietic cell transplantation; Bronchiolitis obliterans syndrome; Graft-versus-host disease; Lung transplantation; Macrophage.

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers
  • Bronchiolitis Obliterans / diagnosis*
  • Bronchiolitis Obliterans / etiology*
  • Child
  • Child, Preschool
  • Disease Management
  • Disease Progression
  • Disease Susceptibility
  • Female
  • Fluorescent Antibody Technique
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Immunohistochemistry
  • Immunophenotyping
  • In Situ Hybridization, Fluorescence
  • Infant
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Macrophages / pathology
  • Male
  • Transplantation, Homologous
  • Young Adult

Substances

  • Biomarkers